Budesonide Industry Research Report 2024

Budesonide Industry Research Report 2024


Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.

Highlights

The global Budesonide market is projected to reach US$ million by 2030 from an estimated US$ million in 2024, at a CAGR of % during 2025 and 2030.
North America is the largest market with about 36% revenue market share. Followed by Asia-Pacific and Europe, accounting for about 60% revenue market share.
The key players are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod etc. AstraZeneca is the largest manufacturer with about 56% revenue market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Budesonide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Budesonide.
The Budesonide market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Budesonide market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Budesonide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

AstraZeneca
Teva
Mylan
Sandoz
Cosmo Pharmaceuticals
Salix
Chiesi Farmaceutici
Orion Corporation
Cipla
Synmosa Biopharma
Lunan Better Pharma
Shanghai Sine Promod

Product Type Insights

Global markets are presented by Budesonide type, along with growth forecasts through 2030. Estimates on sales and revenue are based on the price in the supply chain at which the Budesonide are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2019-2024) and forecast period (2025-2030).
Budesonide segment by Type

Injectable Suspension
Aerosols
Inhalation Powder
Tablet and Capsule

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2019-2024) and forecast period (2025-2030).
This report also outlines the market trends of each segment and consumer behaviors impacting the Budesonide market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Budesonide market.
Budesonide segment by Application

Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment
Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2019-2030.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2023 because of the base year, with estimates for 2024 and forecast revenue for 2030.

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Budesonide market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Budesonide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Budesonide and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Budesonide industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Budesonide.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Budesonide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Budesonide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Budesonide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Budesonide Market Size (2019-2030) & (US$ Million)
2.2.2 Global Budesonide Sales (2019-2030)
2.2.3 Global Budesonide Market Average Price (2019-2030)
2.3 Budesonide by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
1.2.2 Injectable Suspension
1.2.3 Aerosols
1.2.4 Inhalation Powder
1.2.5 Tablet and Capsule
2.4 Budesonide by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Respiratory Disease Treatment
2.4.3 Nose Disease Treatment
2.4.4 Inflammatory Bowel Disease Treatment
2.4.5 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Budesonide Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Budesonide Sales (M Units) of Manufacturers (2019-2024)
3.3 Global Budesonide Revenue of Manufacturers (2019-2024)
3.4 Global Budesonide Average Price by Manufacturers (2019-2024)
3.5 Global Budesonide Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Budesonide, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Budesonide, Product Type & Application
3.8 Global Manufacturers of Budesonide, Date of Enter into This Industry
3.9 Global Budesonide Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 AstraZeneca
4.1.1 AstraZeneca Company Information
4.1.2 AstraZeneca Business Overview
4.1.3 AstraZeneca Budesonide Sales, Revenue and Gross Margin (2019-2024)
4.1.4 AstraZeneca Budesonide Product Portfolio
4.1.5 AstraZeneca Recent Developments
4.2 Teva
4.2.1 Teva Company Information
4.2.2 Teva Business Overview
4.2.3 Teva Budesonide Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Teva Budesonide Product Portfolio
4.2.5 Teva Recent Developments
4.3 Mylan
4.3.1 Mylan Company Information
4.3.2 Mylan Business Overview
4.3.3 Mylan Budesonide Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Mylan Budesonide Product Portfolio
4.3.5 Mylan Recent Developments
4.4 Sandoz
4.4.1 Sandoz Company Information
4.4.2 Sandoz Business Overview
4.4.3 Sandoz Budesonide Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Sandoz Budesonide Product Portfolio
4.4.5 Sandoz Recent Developments
4.5 Cosmo Pharmaceuticals
4.5.1 Cosmo Pharmaceuticals Company Information
4.5.2 Cosmo Pharmaceuticals Business Overview
4.5.3 Cosmo Pharmaceuticals Budesonide Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Cosmo Pharmaceuticals Budesonide Product Portfolio
4.5.5 Cosmo Pharmaceuticals Recent Developments
4.6 Salix
4.6.1 Salix Company Information
4.6.2 Salix Business Overview
4.6.3 Salix Budesonide Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Salix Budesonide Product Portfolio
4.6.5 Salix Recent Developments
4.7 Chiesi Farmaceutici
4.7.1 Chiesi Farmaceutici Company Information
4.7.2 Chiesi Farmaceutici Business Overview
4.7.3 Chiesi Farmaceutici Budesonide Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Chiesi Farmaceutici Budesonide Product Portfolio
4.7.5 Chiesi Farmaceutici Recent Developments
4.8 Orion Corporation
4.8.1 Orion Corporation Company Information
4.8.2 Orion Corporation Business Overview
4.8.3 Orion Corporation Budesonide Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Orion Corporation Budesonide Product Portfolio
4.8.5 Orion Corporation Recent Developments
4.9 Cipla
4.9.1 Cipla Company Information
4.9.2 Cipla Business Overview
4.9.3 Cipla Budesonide Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Cipla Budesonide Product Portfolio
4.9.5 Cipla Recent Developments
4.10 Synmosa Biopharma
4.10.1 Synmosa Biopharma Company Information
4.10.2 Synmosa Biopharma Business Overview
4.10.3 Synmosa Biopharma Budesonide Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Synmosa Biopharma Budesonide Product Portfolio
4.10.5 Synmosa Biopharma Recent Developments
6.11 Lunan Better Pharma
6.11.1 Lunan Better Pharma Company Information
6.11.2 Lunan Better Pharma Budesonide Business Overview
6.11.3 Lunan Better Pharma Budesonide Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Lunan Better Pharma Budesonide Product Portfolio
6.11.5 Lunan Better Pharma Recent Developments
6.12 Shanghai Sine Promod
6.12.1 Shanghai Sine Promod Company Information
6.12.2 Shanghai Sine Promod Budesonide Business Overview
6.12.3 Shanghai Sine Promod Budesonide Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Shanghai Sine Promod Budesonide Product Portfolio
6.12.5 Shanghai Sine Promod Recent Developments
5 Global Budesonide Market Scenario by Region
5.1 Global Budesonide Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Budesonide Sales by Region: 2019-2030
5.2.1 Global Budesonide Sales by Region: 2019-2024
5.2.2 Global Budesonide Sales by Region: 2025-2030
5.3 Global Budesonide Revenue by Region: 2019-2030
5.3.1 Global Budesonide Revenue by Region: 2019-2024
5.3.2 Global Budesonide Revenue by Region: 2025-2030
5.4 North America Budesonide Market Facts & Figures by Country
5.4.1 North America Budesonide Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Budesonide Sales by Country (2019-2030)
5.4.3 North America Budesonide Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Budesonide Market Facts & Figures by Country
5.5.1 Europe Budesonide Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Budesonide Sales by Country (2019-2030)
5.5.3 Europe Budesonide Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Budesonide Market Facts & Figures by Country
5.6.1 Asia Pacific Budesonide Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Budesonide Sales by Country (2019-2030)
5.6.3 Asia Pacific Budesonide Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Budesonide Market Facts & Figures by Country
5.7.1 Latin America Budesonide Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Budesonide Sales by Country (2019-2030)
5.7.3 Latin America Budesonide Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Budesonide Market Facts & Figures by Country
5.8.1 Middle East and Africa Budesonide Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Budesonide Sales by Country (2019-2030)
5.8.3 Middle East and Africa Budesonide Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Budesonide Sales by Type (2019-2030)
6.1.1 Global Budesonide Sales by Type (2019-2030) & (M Units)
6.1.2 Global Budesonide Sales Market Share by Type (2019-2030)
6.2 Global Budesonide Revenue by Type (2019-2030)
6.2.1 Global Budesonide Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Budesonide Revenue Market Share by Type (2019-2030)
6.3 Global Budesonide Price by Type (2019-2030)
7 Segment by Application
7.1 Global Budesonide Sales by Application (2019-2030)
7.1.1 Global Budesonide Sales by Application (2019-2030) & (M Units)
7.1.2 Global Budesonide Sales Market Share by Application (2019-2030)
7.2 Global Budesonide Revenue by Application (2019-2030)
6.2.1 Global Budesonide Sales by Application (2019-2030) & (US$ Million)
6.2.2 Global Budesonide Revenue Market Share by Application (2019-2030)
7.3 Global Budesonide Price by Application (2019-2030)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Budesonide Value Chain Analysis
8.1.1 Budesonide Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Budesonide Production Mode & Process
8.2 Budesonide Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Budesonide Distributors
8.2.3 Budesonide Customers
9 Global Budesonide Analyzing Market Dynamics
9.1 Budesonide Industry Trends
9.2 Budesonide Industry Drivers
9.3 Budesonide Industry Opportunities and Challenges
9.4 Budesonide Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings